Displaying all 2 drugs
Cabotegravir
Cabotegravir, or GSK1265744, is an HIV-1 integrase inhibitor that is prescribed with the non-nucleoside reverse transcriptase inhibitor, rilpivirine.[A227668,L31188,L31193] Early research into cabotegravir showed it had lower oral bioavailability than dolutegravir, which resulted in the development of long acting monthly intramuscular injection formulation for cabotegravir.[A227668,L31193]
Cabotegravir was granted FDA approval on...
Approved
Investigational
Matched Description: … combination product was granted FDA approval for dosing every two months on February 01, 2022 [L40084] and ... A227668,L31188,L31193] Early research into cabotegravir showed it had lower oral bioavailability than [dolutegravir ... -1 integrase inhibitor that is prescribed with the non-nucleoside reverse transcriptase inhibitor, [rilpivirine …
Matched Salts name: … Cabotegravir sodium …
Matched Salts name: … Cabotegravir sodium …
Dolutegravir
Dolutegravir is an HIV-1 integrase inhibitor that blocks the strand transfer step of the integration of the viral genome into the host cell (INSTI). The effect of this drug has no homology in human host cells, which gives it excellent tolerability and minimal toxicity. Dolutegravir was developed by ViiV Healthcare...
Approved
Matched Synonyms: … Dolutegravir …
Matched Name: … Dolutegravir …
Matched Description: … [L1035] On November 21, 2017, dolutegravir, in combination with rilpivirine, was approved as part of ... [A31342] Dolutegravir was developed by ViiV Healthcare and FDA-approved on August 12, 2013. ... The effect of this drug has no homology in human host cells, which gives it excellent tolerability and …
Matched Salts name: … Dolutegravir sodium …
Matched Categories: … dolutegravir and rilpivirine ... lamivudine and dolutegravir ... lamivudine, abacavir and dolutegravir ... lamivudine, tenofovir disoproxil and dolutegravir ... dolutegravir …
Matched Products: … Dolutegravir ... TEGRAD (Dolutegravir Film-Coated Tablets 50mg) …
Matched Name: … Dolutegravir …
Matched Description: … [L1035] On November 21, 2017, dolutegravir, in combination with rilpivirine, was approved as part of ... [A31342] Dolutegravir was developed by ViiV Healthcare and FDA-approved on August 12, 2013. ... The effect of this drug has no homology in human host cells, which gives it excellent tolerability and …
Matched Salts name: … Dolutegravir sodium …
Matched Categories: … dolutegravir and rilpivirine ... lamivudine and dolutegravir ... lamivudine, abacavir and dolutegravir ... lamivudine, tenofovir disoproxil and dolutegravir ... dolutegravir …
Matched Products: … Dolutegravir ... TEGRAD (Dolutegravir Film-Coated Tablets 50mg) …
Displaying all 2 drugs